Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Kenvue Inc. (KVUE:NYSE), powered by AI.
Kenvue Inc. is currently trading at $18.43. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Kenvue Inc. on Alpha Lenz.
Kenvue Inc.'s P/E ratio is 24.0.
“Kenvue Inc. trades at a P/E of 24.0 (fair value) with solid ROE of 14.4%.”
Ask for details →Kenvue Inc. is a consumer healthcare and pharmaceutical company. It focuses on delivering a range of health-centric products, spanning hygiene, pain relief, and other wellness categories. With deep-rooted expertise in pharmaceuticals, Kenvue Inc. targets the health and wellness needs of individuals, providing both prescription and over-the-counter solutions. The company has established itself as a vital entity in the consumer health sector, significantly impacting community health standards and individual lives. Positioned in the pharmaceutical industry, Kenvue Inc. collaborates with healthcare providers to enhance its product reach and efficacy. Its broad portfolio includes well-known brands and formulations that are trusted globally by consumers seeking reliable health solutions. As a player in this sector, Kenvue Inc. contributes to the enhancement of public health, highlighting its prominence in both domestic and international markets.
“Kenvue Inc. trades at a P/E of 24.0 (fair value) with solid ROE of 14.4%.”
Ask for details →Kenvue Inc. (ticker: KVUE) is a company listed on NYSE in the Consumer Defensive sector (Household & Personal Products). It has approximately 22,000 employees. Market cap is $35.3B.
The current price is $18.43 with a P/E ratio of 24.03x and P/B of 3.28x.
ROE is 14.39% and operating margin is 17.95%. Annual revenue is $15.1B.